Allosteric SHP2 inhibitors suppress lung cancer cell migration by inhibiting non-canonical activation of EphA2 via the ERK-RSK signaling pathway

Khanh Cong Nguyen(National Institute Of Hygiene And Epidemiology), Hiroaki Sakurai(Institute of Natural Science)
Scientific Reports
October 22, 2025
Cited by 1


Related Papers